Importantly, tumor cells develop myriad ways to escape T-cell-mediated cytotoxicity including the expression of negative immune checkpoints e.g. PD-L1, overexpression of soluble immunosuppressants, diminished antigen presentation, and a shift toward an M2-dominant macrophage infiltrate [16, 17]. The gene discussed is CD274; the disease is neoplasm.